Pliant Therapeutics Inc (PLRX)
13.45
-0.32
(-2.32%)
USD |
NASDAQ |
Nov 14, 11:03
Pliant Therapeutics Market Cap: 818.48M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
November 13, 2024 | 837.95M |
November 12, 2024 | 841.00M |
November 11, 2024 | 882.99M |
November 08, 2024 | 912.80M |
November 07, 2024 | 924.37M |
November 06, 2024 | 955.40M |
November 05, 2024 | 906.72M |
November 04, 2024 | 881.77M |
November 01, 2024 | 883.59M |
October 31, 2024 | 856.15M |
October 30, 2024 | 876.84M |
October 29, 2024 | 895.70M |
October 28, 2024 | 904.22M |
October 25, 2024 | 861.02M |
October 24, 2024 | 832.42M |
October 23, 2024 | 864.67M |
October 22, 2024 | 890.23M |
October 21, 2024 | 892.05M |
October 18, 2024 | 924.91M |
October 17, 2024 | 892.66M |
October 16, 2024 | 920.04M |
October 15, 2024 | 851.89M |
October 14, 2024 | 835.46M |
October 11, 2024 | 830.60M |
October 10, 2024 | 705.85M |
Date | Value |
---|---|
October 09, 2024 | 698.55M |
October 08, 2024 | 683.95M |
October 07, 2024 | 676.65M |
October 04, 2024 | 701.59M |
October 03, 2024 | 676.65M |
October 02, 2024 | 663.87M |
October 01, 2024 | 641.96M |
September 30, 2024 | 682.12M |
September 27, 2024 | 687.66M |
September 26, 2024 | 679.15M |
September 25, 2024 | 688.88M |
September 24, 2024 | 688.88M |
September 23, 2024 | 688.27M |
September 20, 2024 | 738.13M |
September 19, 2024 | 767.31M |
September 18, 2024 | 760.02M |
September 17, 2024 | 766.10M |
September 16, 2024 | 721.71M |
September 13, 2024 | 729.62M |
September 12, 2024 | 719.89M |
September 11, 2024 | 745.43M |
September 10, 2024 | 789.20M |
September 09, 2024 | 783.12M |
September 06, 2024 | 782.51M |
September 05, 2024 | 811.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
148.66M
Minimum
May 11 2022
2.051B
Maximum
Jan 31 2023
901.84M
Average
902.07M
Median
Market Cap Benchmarks
Haemonetics Corp | 4.644B |
Marker Therapeutics Inc | 34.44M |
Aligos Therapeutics Inc | 69.14M |
Korro Bio Inc | 520.55M |
CEL-SCI Corp | 36.28M |
Market Cap Related Metrics
PS Ratio | 161.34 |
Price to Book Value | 2.367 |
Price | 13.45 |
Earnings Yield | -24.83% |